SCHEMBL20494864

SCHEMBL20494864

CCOC(=O)c1nc(C2CC(C(F)(F)F)C2)sc1N1CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ PIK3CA P42336 1/20 0.40
▸ MTOR P42345 8/20 0.38
▸ HSD17B10 Q99714 5/20 0.38
▸ HPGD P15428 4/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ SIRT2 Q8IXJ6 1/20 0.36
▸ SIRT1 Q96EB6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20580222 0.86 ALDH1A1 (0.46) KDM4EALDH1A1L3MBTL1PIK3CAMTOR
SCHEMBL18395215 0.84 ALDH1A1 (0.44) KDM4EALDH1A1L3MBTL1PIK3CAMTOR
SCHEMBL18395121 0.83 ALDH1A1 (0.43) KDM4EALDH1A1L3MBTL1PIK3CAMTOR
SCHEMBL18395298 0.79 KDM4E (0.46) KDM4EALDH1A1L3MBTL1PIK3CAMTOR
SCHEMBL18394877 0.78 KDM4E (0.45) KDM4EALDH1A1L3MBTL1PIK3CAMTOR
SCHEMBL18394620 0.77 ALDH1A1 (0.49) KDM4EALDH1A1L3MBTL1PIK3CAMTOR
SCHEMBL20867219 0.76 ALDH1A1 (0.51) KDM4EALDH1A1L3MBTL1PIK3CAMTOR
SCHEMBL18394319 0.76 ALDH1A1 (0.48) KDM4EALDH1A1L3MBTL1PIK3CAMTOR
SCHEMBL18394751 0.75 KDM4E (0.46) KDM4EALDH1A1L3MBTL1PIK3CAMTOR
SCHEMBL20098203 0.74 ALDH1A1 (0.47) KDM4EALDH1A1L3MBTL1PIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10570153-B2 Benzodiazepine derivatives as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2020-02-25 — — US disclosed
US-20180258102-A1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2018-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570153-B2 Benzodiazepine derivatives as RSV inhibitors GABRA5, GABRA1, GABBR2 KDM4E 1198/4885ALDH1A1 621/4885L3MBTL1 4773/4885
US-20180258102-A1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS GABRA5, GABRA1, GABBR2 KDM4E 1198/4885ALDH1A1 621/4885L3MBTL1 4773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback